MetaImmuneTech Co., Ltd. (CEO Hyunsik Jeon) announced that it will participate in ‘CES 2024’, the world’s largest IT and home appliance exhibition held in Las Vegas, USA in January, and introduce its immune cell analysis solution.
MetaImmuneTech is a startup established in November 2020, and its greatest value and vision is ‘a world where health status can be determined by looking at cells’.
Under this commitment, the company has specialized in utilizing ‘Lens-free Shadow Imaging (LSIT)’ technology, and has expanded its technological capabilities to include digital in-line holograms based on LSIT, creating a new concept cell diagnostic platform ‘Cellytics’. succeeded in developing
The Cellytics platform is based on the function of ‘Cellytics NK’, which collects various information about cells as a digital in-line hologram. It is a device that captures the unique characteristics of cells, such as their size, shape, and cytoplasmic complexity, and the results collected through this are analyzed using the machine learning (ML) algorithm provided by the platform. As a result, the company explains that precise analysis at the single cell level is possible with a relatively simple image acquisition procedure.
Cellytics, which has secured not only speed and accuracy, but also convenience and price competitiveness compared to existing cell analysis solutions, is expected to contribute to expanding private access to cell analysis, and in recognition of this vision and technological differentiation, the US, the host of CES, The Consumer Technology Association (CTA) also selected it for the CES 2024 Innovation Award in the Digital Health category.
Regarding this, MetaImmuneTech said, “The Cellytics platform provides the convenience of quickly and accurately analyzing thousands of cells at the same time through unique machine learning algorithm technology, and ADC technology allows all pretreatment at room temperature without separate cell culture. “With these advantages, even non-experts can easily use it, and it can be effectively used for measuring immune cell function in addition to NK cell activity, latent tuberculosis, cell classification, cell therapy verification, and environmental toxicity verification, etc.” emphasized.
He continued, “The Cellytics platform is the first digital immunodiagnostic technology that will revolutionize the complex and expensive cell analysis market, and it allows us to easily monitor an individual’s immunity anytime, anywhere, making our lives healthier in the post-corona era. He added, “The platform’s core source technology has already been patented, and a patent application for ASC technology is also in progress, so we are confident that we will achieve a leading position in the cell analysis field.”
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition that provides insight into the trends of the global home appliance industry at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi